Process View
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cellular hyperosmotic response"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FBXO33 | F-box protein 33 | 0.821 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.388 | ||
| PABPC4 | poly(A) binding protein, cytoplasmic 4 (inducible form) | 0.365 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.159 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.139 | ||
| EIF4A1 | eukaryotic translation initiation factor 4A1 | 0.082 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.081 | ||
| SRSF9 | serine/arginine-rich splicing factor 9 | 0.080 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.077 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.068 | ||
| YBX1 | Y box binding protein 1 | 0.060 | Human | |
| EIF4G1 | eukaryotic translation initiation factor 4 gamma, 1 | 0.055 | ||
| ILF2 | interleukin enhancer binding factor 2, 45kDa | 0.048 | ||
| CSDA | cold shock domain protein A | 0.045 | ||
| CUL1 | cullin 1 | 0.044 | ||
| EPOR | erythropoietin receptor | 0.033 | ||
| FAM107A | family with sequence similarity 107, member A | 0.032 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.029 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.029 | ||
| FBXW7 | F-box and WD repeat domain containing 7 | 0.029 | ||
| CEP110 | centrosomal protein 110kDa | 0.029 | ||
| FLNB | filamin B, beta | 0.027 | ||
| HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 0.024 | ||
| HOXA1 | homeobox A1 | 0.022 | ||
| THOC5 | THO complex 5 | 0.022 | ||
| RHOA | ras homolog gene family, member A | 0.022 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.022 | ||
| EIF4A3 | eukaryotic translation initiation factor 4A3 | 0.020 | ||
| NPM1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | 0.019 | ||
| HABP4 | hyaluronan binding protein 4 | 0.019 | ||
| PTN | pleiotrophin | 0.018 | ||
| IGF2BP2 | insulin-like growth factor 2 mRNA binding protein 2 | 0.017 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.017 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.017 | ||
| PABPC3 | poly(A) binding protein, cytoplasmic 3 | 0.016 | ||
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.016 | ||
| NONO | non-POU domain containing, octamer-binding | 0.015 | ||
| SMU1 | smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) | 0.015 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.015 | ||
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.014 | ||
| CATSPER1 | cation channel, sperm associated 1 | 0.012 | ||
| MAP2K6 | mitogen-activated protein kinase kinase 6 | 0.012 | ||
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.012 | ||
| LSM10 | LSM10, U7 small nuclear RNA associated | 0.011 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.010 | ||
| DDN | dendrin | 0.010 |